LIJENTA-M contains Linagliptin + Metformin Hydrochloride. It is a combination oral antidiabetic medicine used to improve blood glucose control in adults with type 2 diabetes mellitus. Linagliptin helps increase insulin release and reduce glucose production after meals, while metformin reduces glucose production in the liver and improves insulin sensitivity.
Uses:
Management of type 2 diabetes mellitus
Helps control blood glucose levels along with diet and exercise
Used when metformin alone or other antidiabetic medicines are not sufficient
Helps maintain better long-term blood sugar control
Dose:
Adults: Usually 1 tablet once or twice daily with meals, or as directed by a physician
Take with food to reduce stomach discomfort
Dose depends on blood glucose levels, kidney function, and previous diabetes treatment
Swallow the tablet as directed; do not crush or chew if it is an extended-release formulation
Do not stop or change the dose without medical advice
Regular monitoring of blood glucose and kidney function may be required during treatment